News
New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, ...
7d
ScienceAlert on MSNOne Dietary Supplement Shown to Reduce Aggression by Up to 28%Across all the trials, a modest but noticeable short-term effect was found, translating to up to a 28 percent reduction in aggression across multiple different variables (including age, gender, ...
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
A newly published, multicenter clinical trial in the Journal of Wound Care presents promising evidence supporting the use of a botanical-based hydrogel for the management of diabetic foot ulcers (DFUs ...
Integration of trial sequential analysis to control random errors in meta-analysis findings ... Figure 1 shows the PRISMA flow diagram of the literature selection in this study. Actual screening ...
10d
Verywell Health on MSN13 Ways to Lower Your Heart RateYou can lower your heart rate with lifestyle changes like regular exercise and stress management. Learn more tips and when to ...
BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to ...
Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...
7d
GlobalData on MSNProtocol flexibility and navigating the US geopolitical landscape in oncology clinical trialsAt CTO East Coast, experts reflected on designing oncology clinical trials for success and how to account for a shifting geopolitical landscape in the US.
As previously announced with regard to the EU, the clinical trial approval with EMA was granted under the condition that the Company present results of appropriate nonclinical GLP studies before ...
Design The study cohort comprised 89 healthy individuals and 496 HBV-infected patients, with subgroups of 30 and 42 participants receiving randomised nucleos(t ... metabolomics sequencing, flow ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results